CLDN6 X 4-1BB BsAb

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameCLDN6 X 4-1BB BsAb

Drug Alias NameCLDN-6 X 4-1-BB BsAbCLDN6 X 4-1BB BsAb

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-CLDN6Tumor necrosis factor receptor superfamily member 9 agonists

TargetsClaudin 6Tumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesI-Mab Biopharma Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesI-Mab Biopharma Co Ltd

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A